| Bioactivity | (S)-Higenamine ((S)-Norcoclaurine) hydrobromide, a S-enantiomer of Higenamine, is the entry compound in benzylisoquinoline alkaloid biosynthesis. (S)-Higenamine hydrobromide is produced by the condensation of dopamine and 4-hydroxyphenylacetaldehyde (4-HPAA) by norcoclaurine synthase (NCS)[1]. |
| Invitro | The biosynthetic pathway leading to benzylisoquinoline alkaloids originates from the enzyme-catalyzed condensation of dopamine and 4-hydrophenylacetaldehyde to yield (S)-norcoclaurine. Both substrates are secondary metabolites derived from the decarboxylation/hydroxylation/deamination of tyrosine[1]. |
| Name | (S)-Higenamine hydrobromide |
| CAS | 105990-27-0 |
| Formula | C16H18BrNO3 |
| Molar Mass | 352.22 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
(S)-Higenamine hydrobromide
CAS: 105990-27-0 F: C16H18BrNO3 W: 352.22
(S)-Higenamine ((S)-Norcoclaurine) hydrobromide, a S-enantiomer of Higenamine, is the entry compound in benzylisoquinoli
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.